What Is Heparin?
Heparin is a drug used to treat blood clots. It prevents blood from clotting which may cause bleeding or blockage of other organs. It is commonly used to prevent death due to heart attack, stroke, pulmonary embolism, and other blood clots.
It is not just used for treating blood clots, but it is also used to prevent blood loss during surgery and trauma. It helps to stop bleeding after a wound has been cleaned properly. It is also used to dissolve certain types of kidney stones.
For people who have certain blood clotting conditions, heparin can increase the risk of developing a serious condition known as toxic blood syndrome. This syndrome can be fatal if not treated immediately.
Heparin is available in many different forms, such as injection or given by injection into a vein. It is usually stored in a refrigerator to keep it from breaking down.
Heparin should only be used under the supervision of a doctor. If the patient has an ongoing injury or surgery they should stop taking heparin at least two weeks before the procedure and tell their doctor.
People with liver disease or taking certain other medications should not take heparin. It is also not recommended for people who have had an allergic reaction to it in the past.
Heparin can affect certain types of drugs such as those used for treating psychiatric conditions. Patients who take these drugs should tell their doctor if they use heparin.
The most common side effect of heparin is bleeding. It can also increase the risk of bruising, swelling and fitfulness in young children. It may rarely cause low blood sugar, chest pain, coughing, trouble breathing, and unusual changes in behavior or mood.
Severe allergic reactions are rare.
Heparin may interact with other drugs. Tell your doctor all the medications and supplements you use.
An overdose of heparin is very unlikely, but it can happen. Seek immediate medical attention if you think you have used too much heparin.
- Heparin (J Hirsh – New England Journal of Medicine, 1991 – Mass Medical Soc)
- Heparin–protein interactions (I Capila, RJ Linhardt – Angewandte Chemie International …, 2002 – Wiley Online Library)
- Effect of heparin and heparin fractions on platelet aggregation (EW Salzman, RD Rosenberg, MH Smith… – The Journal of …, 1980 – Am Soc Clin Investig)
- Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin (TE Warkentin, MN Levine, J Hirsh… – … England Journal of …, 1995 – Mass Medical Soc)
- Anticoagulant action of heparin (PS Damus, M Hicks, RD Rosenberg – Nature, 1973 – Springer)
- Heparin Induced Thrombocytopenia (HIT) (J Amiral, AM Vissac – Thromb. Haemostasis, 1992 – scientific-hemostasis.com)
- Heparin-associated thrombocytopenia (DJ King, JG Kelton – Annals of internal medicine, 1984 – acpjournals.org)
- Temporal aspects of heparin-induced thrombocytopenia (U Lindahl, L Kjellén – Thrombosis and haemostasis, 1991 – Schattauer GmbH)
- Low molecular weight heparin (TE Warkentin, JG Kelton – New England Journal of Medicine, 2001 – Mass Medical Soc)